Heterocyclic compound and use thereof
US9493484B2 · kind B2 · utility
2Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2013 |
| Grant date | Nov 15, 2016 |
| Priority date | — |
| Expiry date | Feb 7, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a compound having an AMPA receptor function enhancing action, and useful as a prophylactic or therapeutic drug for depression, schizophrenia, Alzheimer's disease, attention deficit hyperactivity disorder (ADHD) and the like. The compound represented by formula (I):wherein each symbol is as defined in the DESCRIPTION, or a salt thereof has an AMPA receptor function enhancing action, and is useful as a prophylactic or therapeutic drug for depression, schizophrenia, Alzheimer's disease or attention deficit hyperactivity disorder (ADHD) and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.